Pfizer asks journal for comments made by peer reviewersBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39518.526389.DB (Published 13 March 2008) Cite this as: BMJ 2008;336:575
- Clare Dyer
The multinational drug company Pfizer is trying to force leading medical journals to divulge the identities and comments of anonymous peer reviewers who judged articles submitted about two of the company’s painkillers.
Pfizer, which is facing a claim for damages by users of the cyclo-oxygenase-2 inhibitors celecoxib (Celebrex) and valdecoxib (Bextra), has issued subpoenas against journals including the New England Journal of Medicine, JAMA, the BMJ, and the Lancet.
Editors and researchers fear the move could threaten the confidentiality of the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial